drugset / Trial / NCT00516659

ETEC Logistics Trial (TREK)

NCT00516659 ↗

Phase 2 Completed 201 enrolled Intercell USA, Inc.
RandomizedFactorialDouble-blind

Summary

This is a multicenter, double-blind, randomized, placebo-controlled field trial to evaluate the epidemiology of natural infection with ETEC occurring after transcutaneous immunization in a field setting.

Timeline

Start
2006-05
Primary completion
2007-01
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heat-Labile Enterotoxin of Escherichia coli Vaccine 37.5 ug Other

Indications